‹ ›

Diabetes Care for All: Building Best Practice



Register now for the fourth annual Diabetes Frontline Forum!

Event Date: Friday April 28, 2023
Time: 9:30 a.m. to 6:15 p.m. EST
 

When:

Friday April 28, 2023, from 9:30 a.m. to 6:15 p.m. EST

Where:

Virtual! Join from anywhere and attend this event without leaving the comfort of your own home.
Recordings will be available post-event

Tickets:

$35 (Diabetes Canada Professional Member)
$50 (General Registration)


Join us for the fourth annual National Diabetes Frontline Forum!

Diabetes Frontline Forum (DFF), in its fourth year, provides allied health care professionals with an excellent opportunity to learn from diabetes experts, network with colleagues, and learn from the latest industry trends.

Event highlights include:

  • One-day virtual education
  • Opportunity to network with hundreds of attendees across Canada, through our new Table Talks feature
  • Live exhibitor tradeshow

Sponsors & Donors

Exhibitor Tradeshow

Coming Soon

Table Talks


New this year, virtual roundtable discussions where attendees can share ideas about a topic in a small group setting. You’ll be able to discuss important diabetes topics and solve problems together.

Taking place at 12:00pm to 1:00pm and 4:45pm to 5:45pm, attendees will spend 15 minutes at the table of their choice four times throughout the hour.

Diabetes Canada Auditorium - Agenda

All presentations are in Eastern Standard Time (EST)

08:30 - 9:30 a.m.

Exhibitor Trade Show

09:30 - 10:15a.m.

Session 1: After T2D Diagnosis

Ciara is an RN and Certified Diabetes Educator residing in the beautiful Annapolis Valley, Nova Scotia. She herself has lived with Type 1 Diabetes for over 25 years. She has worked with people who live with diabetes in a variety of healthcare settings, including both Critical and Primary Care. Recently, Ciara has become especially interested in working with people who live with Type 2 Diabetes. She hopes to help extinguish the shame, stigma and misinformation that often surrounds Type 2 Diabetes, both within general society and the institution of healthcare itself. She aims to live life outside of her comfort zone, and ultimately hopes to help others living with diabetes to do the same. She is a self-proclaimed fitness and wellness nerd, and is currently training for her first sprint triathlon.

Ciara StevensR.N., CDE

Transitional times can be difficult. We know that transitions throughout one’s experience with diabetes can be especially precarious. This presentation will shine a light on the healthcare journey and transitions that a person living with Type 2 Diabetes (PLWT2D) experiences from diagnosis onwards. The aim of this presentation is to improve care, so that the PLWT2D can be better prepared with what to expect in terms of care transitions, potential barriers and available resources. The presentation will also consider at how diabetes distress, trauma and stigma play into the experience.

Learning Objectives:

  1. To explain the importance of addressing and acknowledging the stigma, shame, diabetes distress and sense of fatalism that a person living with Type 2 Diabetes may experience.
  2. To improve the understanding of the transition points within care for a person living with Type 2 Diabetes.
  3. To identify practical tips to help set their patients up for success when they have been recently diagnosed with Type 2 Diabetes.

10:15 - 11:00 a.m.

Session 2: The role of community care in diabetes prevention & management

Yazid is a clinical pharmacist who is currently an Assistant Professor at the Faculty of Medicine and Dentistry at the University of Alberta, the Scientific Officer of the Alberta SPOR SUPPORT Unit and the Associate Director of the EPICORE Centre. He obtained his BSc in pharmacy from the University of Jordan and his PhD from Queen’s University Belfast. His main research interests are chronic disease prevention and management with special interest in CVD and pharmacy practice. This research involves focusing on prevention, increasing awareness, improving control and management of cardiovascular disease and its risk factors as well as making the paradigm shift in pharmacy practice to focus on patient-centered care.

Yazid Al HamarnehPhD

This engaging session will discuss the need for community care in diabetes prevention and management. It will describe some of the evidence of the benefits of the interventions of community primary care providers, particularly pharmacists, in patients with diabetes and discuss some practical tips that community care providers could use when caring for patients with diabetes using case studies.

Learning Objectives:

  1. To describe the need for community care in diabetes prevention and management.
  2. To improve understanding of the benefits of community care interventions.
  3. To identify practical tips that could be used in practice when caring for patients with diabetes

11:00 - 11:45 a.m.

Session 3: Cardiorenal Risk Reduction Don't forget about the ABCDESSS

Dr. Daniel Ngui is a family physician and is the medical director for an interdisciplinary group family practice of 8 family physicians, three nurse practitioners, a clinical pharmacist team and A chronic disease nurse at Fraser Street Medical in South Vancouver.

He is a clinical professor with the UBC Dept of Family Medicine involved in teaching medical trainees and family practice residents from the St. Paul’s hospital programs. He is co-chair for the popular and St. Paul’s CME program which has an annual attendance between 1200-1500 clinicians. He is involved with several national physician organizations focused on medical education and knowledge translation of guidelines and develops CME programs and speaks at the local, regional and national level.

Daniel NguiMD


11:45 - 12:00 p.m

BREAK - Be sure to check out the Exhibitor Trade Show


12:00 a.m - 1:00 p.m.

Table Talks: ADA guidelines for people with T2D and CKD - Sponsored by Bayer

Dr. Silva has been a staff nephrologist at Trillium Health Partners since 2012. She graduated from medical school from Universidad Evangelica of El Salvador and completed internal medicine training at Queens University. She obtained her nephrology fellowship from the University of Western Ontario and her Hypertension Specialist designation from the American Heart Association. She spends time in clinical research, chairs the Peritoneal dialysis council at THP, is an Investigator at the Institute for Better Health. Clinical lecturer, at the University of Toronto.

Veronica SilvaMD


1:00 - 1:45 p.m.

Session 4: Exercise Movement for All

Jean Fraser


1:45 - 2:30 p.m.

Session 5: Roadmap to Insulin Adjustments

Susie is a primary care pharmacist, Certified Diabetes Educator, Certified Fitter of Compression Therapy and Certified Respiratory Educator. Within Diabetes Canada, Susie is a chapter author of the Clinical Practice Guidelines (CPGs), including the NEW Remission of Type 2 Diabetes chapter and User’s Guide, a member of the Dissemination and Implementation Committee of the CPGs, an Associate Editor for The Diabetes Communicator, and Professional Conference Co-Chair. With Wounds Canada, Susie is on the Board of Directors and a co-author of Wounds Canada Best Practice Recommendations. Provincially, Susie serves on the Ontario Immunization Advisory Committee. Susie is humbled to have received prestigious national awards: The 2020 Charles H. Best Award, given to a healthcare professional who has made a significant difference across Canada towards improving the quality of life of individuals living with diabetes; and the 2021 Diabetes Canada Educator of the Year

Susie JinPharmacist, CDE, CPT, CRE

Studies continue to demonstrate that more than 50% of people with diabetes live with an A1C above 7.0%. Similarly, many people with type 2 diabetes who have been prescribed insulin, are either not optimizing their insulin dose and/or are experiencing adverse effects of insulin. The session will begin with a step-wise approach to adjusting/advancing insulin. Consideration of common factors that affect insulin pharmacodynamics and pharmokinetics will be discussed to support an increase in the effectiveness of insulin and a reduction in adverse effects. Finally, two practical case scenarios will be examined wherein insulin should be optimized in a person’s diabetes management. This engaging session will provide participants with a roadmap to insulin adjustments such that participants can apply learnings to support individuals in their journey with type 2 diabetes.

Learning objectives:

  1. To describe a step-wise approach to advancing/adjusting insulin in people with type 2 diabetes (PwT2D)
  2. To explain to PwT2D how to account for the factors that affect insulin in the body such that insulin variability is minimized
  3. To identify common scenarios wherein insulin therapy requires optimization

2:30 - 3:15 p.m.

Session 6: Remission of Type 2 Diabetes

Kaberi Dasgupta is a Physician, Scientist, and Professor of Medicine at McGill University and the McGill University Health Centre. Her research focus is prevention, remission, and self-management support in diabetes. Her research is funded by the CIHR, Heart & Stroke Foundation, Lawson Foundation, and Diabetes Canada. She has published over 140 papers and her research has received a high level of media coverage because of its direct relevance to patients, practitioners, and policy makers. She is co-author of Diabetes Canada clinical practice guidelines on remission, physical activity, and type 2 diabetes pharmacotherapy. She is the Director of the Centre for Outcomes Research and Evaluation (CORE) at the Research Institute of the McGill University Health Centre.

Kaberi DasguptaMD

Jenna Walsh completed her degree in Human Nutrition at the University of Guelph, followed by a dietetic internship through the Ottawa Hospital. She has been working as a clinical RD in Renfrew County since 2010, dividing her time between Long Term Care, inpatient and outpatient support, private practice, as well as community nutrition, including developing and coordinating Kids in the Kitchen, and more recently, a Virtual Eating Disorders Support Program. She added CDE to her resume in 2017 and continues to support those living with diabetes in her community by normalizing food and movement as part of their diabetes management. She loves spending time outdoors with her spouse and 3 daughters and in the kitchen whipping up new recipes.

Jenna WalshRD

Since the release of the Diabetes Canada guidelines on Remission for Type 2 Diabetes in 2022, many questions have emerged about practical considerations. This session will review the guidelines and studies from which the evidence has been drawn. It will discuss the effectiveness of a low-energy diet intervention and compare risks and benefits. It will also highlight the ongoing RESET for REMISSION trial combining low-energy diet with supervised exercise. Finally, participants will leave this session with practical suggestions for addressing remission in their practice.

Learning Objectives:

  1. To become familiar with the new Diabetes Canada Clinical Practice Guidelines for Remission for Type 2 Diabetes
  2. To understand the effectiveness of a low-energy diet intervention in people with Type 2 diabetes through a review of the DiRECT and DIADEM trials
  3. To discuss the ongoing RESET for REMISSION trial that is combining low-energy diet with supervised exercise.
  4. To compare nutritional risks and benefits
  5. To provide practical suggestions for 10 minute appointment

3:15 - 3:30 p.m.

Break - Be sure to check out the Exhibitor Trade Show

Industry Auditorium - Agenda

All presentations are in Eastern Standard Time (EST)


3:30 - 3:50 p.m.

Sponsored Talk 1 - Abbott: Providing a clear picture today How CGM can help patients visualize the impact of daily activities on glycemic control

Michael Boivin is a clinical pharmacist consultant, continuing education developer and president of CommPharm Consulting Inc. In 2009, he left full-time pharmacy practice to pursue a career in continuing education and consulting. He has developed in excess of 500 accredited continuing education activities for pharmacists, family physicians, specialists and allied healthcare professionals.

Michael BoivinBsc. Phm, RPH, CDE, CTH

The use of continuous glucose monitoring (CGM) is increasingly becoming the standard of care for patients using insulin to manage their diabetes. With the level of data collected by CGM and the clear data presentation with time-in-range and ambulatory glucose profile (AGP) tools, this technology is being increasingly used by people with diabetes to visualize the impact of behaviours (e.g. diet, physical, medication adherence) on glycemic control. This short and practical session will focus on the value of CGM use at diagnosis of type 2 diabetes and its emerging role of setting up optimal management early.

Learning Objectives:

  1. Explain the challenges of determining appropriate behaviour changes at diagnosis for a person with type 2 diabetes.
  2. Determine the potential role of continuous glucose monitoring (CGM) data in helping to promote appropriate behaviour changes for optimal glycemic control.
  3. Educate a person with type 2 diabetes on how to fully utilize CGM to optimize glycemic control at diagnosis.

3:55 - 4:15 p.m.

Sponsored Talk 2 - Novo Nordisk: Rethinking GLP-1 RAs in Type 2 Diabetes 

Dr. Noronha graduated from the University of Toronto medical school in 1990 and completed his family medicine residency there in 1992. He was awarded the Gaynor Dawn Memorial scholarship in family medicine. He is the medical director of the Stirling Manor and the lead physician for the Belleville Family Health Organization (FHO). He has been a clinical investigator in many pharmaceutical studies and is published in peer reviewed journals. He has a passion for CME and has given over 250 talks to other physicians as well as nurses, pharmacists, and diabetes educators over the years.

Lionel NoronhaMD, CCFP, FCFP

This session will provide practical tips for primary care providers and allied health professionals who manage patients with T2D and multiple comorbidities. This session will review pertinent clinical trial results and present a complex patient case to highlight the importance of early initiation of GLP-1 RAs and individualized treatment strategies for patients with T2D.

Learning Objectives:

  1. Assess recent evidence for the initiation of GLP-1 RAs in patients with T2D and multiple comorbidities
  2. Review practical patient-management considerations for GLP-1 RAs

4:20- 4:40 p.m.

Sponsored Talk 3 - Dexcom: Real-time CGM is Changing Practice: My Eureka Moments and Quick Tips for Success with rtCGM

Alanna Chambers is a Registered Dietitian and Certified Diabetes Educator from Kelowna, BC who brings passion to her work in the type 1 diabetes space.  She is currently focussing her time on community insulin pump and sensor trainings, while also working casually at the Central Okanagan Diabetes Centre. She has been enjoying tackling the 'ins-and-outs' of the latest technology advances in diabetes.  Previously, she spent nearly 10 years working in the insulin pump industry and also enjoyed volunteer work at Diabetes Summer Camps, and being on staff with numerous Children with Diabetes conferences.  She enjoys blending her professional and personal experiences in type 1 diabetes to try to make a difference. She has 3 young girls who keep her on her toes at home!

Alanna ChambersRD, CDE

This session will demonstrate how rtCGM has changed their diabetes practice, practical strategies for quick and effective rtCGM use in pharmacy or the diabetes clinic, and highlights from the latest CGM outcome trials.


4:45 - 5:05 p.m.

Sponsored Talk 4

Event Advisory Committee

Zaina Albalawi

MD, MSc, FRCPC

Lynn Baughan

RN, MN, CDE

Lisa DeMolitor

MPH, PDt, CDE

Jeffrey Habert

MD, CCFP, FCFP

Kristin Honshorst

MSs, Senior Manager, HCP Education and Engagement Diabetes Canada

Akshay Jain

MD, FRCPC, FACE, CCD, ECNU, DABOM

Susie Jin

RPh, CDE CRE

Gail MacNeill

Trish Molberg

RPh, CDE

Eilyn Rodriguez

BEng, MASc, Director of Development, Corporate Partnerships, Diabetes Canada

Disclaimer: “As a participant in this virtual conference, you hereby acknowledge and agree to the following terms: Diabetes Canada (DC) in no way sponsors or endorses the information shared or presented amongst speakers. Any products and/or services presented are in no way promoted or endorsed by DC or its affiliates. Any information presented during this event should not be recorded or published, including shared on any social media platforms or any forum outside the virtual conference whatsoever. Sharing this information is prohibited and remains the intellectual property of Diabetes Canada and its affiliates”.

DC reserves the right to vary any of the speakers, topics, and/or times without further notice.

The Diabetes Frontline Forum virtual conference contains links to external websites that are not provided or maintained by or in any way affiliated with Diabetes Canada. Please note that Diabetes Canada does not guarantee the accuracy, relevance, timeliness, or completeness of any information on these external websites. You agree that should you decide to use any links to any third-party websites referenced or linked from the Diabetes Frontline Forum, you do so at your own risk. You further agree that your use of such third-party website shall be subject to the terms and conditions and privacy policies of such third-party.

Akshay Jain

MD, FRCPC, FACE, CCD, ECNU, DABOM

Dr. Akshay Jain is the first Canadian physician to be triple board-certified by the American Boards in Endocrinology, Internal Medicine and Obesity Medicine. He trained in Internal Medicine at Rochester, NY where he became the only 4-time winner of the prestigious Rochester Academy of Medicine Awards. He completed his Fellowship in Endocrinology at Harbor UCLA/City of Hope in Los Angeles, CA.

He is the only non-American physician to win the AACE Rising Star in Endocrinology Award (2022) and to feature on Medscape’s list of 25 Top Rising Stars of Medicine (2020). He is the first North American to win the prestigious Etzwiler Diabetes Scholarship at the International Diabetes Center and Mayo Clinic in MN, USA. In 2017, he was awarded the Rising Star of Diabetes Award at the International Symposium on Diabetes.

He is a renowned educator and has spoken at over 800 medical conferences/events across the world till date. His clinical interests include diabetes, obesity, thyroid disorders and osteoporosis.

He has active YouTube/Instagram channels dedicated to patient education with thousands of views till date. He is fluent in 6 languages including English, Hindi, Gujarati, Marathi, Marwari and Urdu. In 2022, he won the Top 25 Canadian Immigrant Award and also received the 2022 Healthcare Achievement Award by Drishti Magazine.

Jeffrey Habert

MD, CCFP, FCFP

Dr. Jeffrey Habert is a Family Physician in Thornhill for the last 33 years. He is an Assistant Professor in the Dept. of Family and Community Medicine at the University of Toronto. He is also an Investigating Coroner for the City of Toronto and a Peer Leader at OntarioMD. He is also Co-Editor of Canadian Primary Care Today (launching Q1 2023) .

Dr. Habert is a former Peer Assessor for the College of Physicians and Surgeons of Ontario (19 years). He has an interest in the use of clinical practice guidelines, and has participated on committees to establish guidelines in the areas of Depression, Stroke, ASA in Primary Care and Thrombosis. He is the Previous co-chair of Thrombosis Canada Clinical Guides.

His clinical interests are varied, and include Diabetes, Obesity, Respiratory Disease, Depression, ADHD, Insomnia, Thrombosis/Stroke and Osteoporosis.

He is also published in many of the above mentioned areas in addition to others.

He is a National speaker in the multiple areas and actively participates on Scientific Committees involved in the creation of educational programs.

Lisa DeMolitor

MPH, PDt, CDE

Lisa is a Dietitian and Certified Diabetes Educator from the Annapolis Valley in Nova Scotia. She completed her Master’s in Public Health through the University of Waterloo. Her passion for helping support people to live well with diabetes is inspired by her 14 years of working as a Diabetes Educator- as well as her love of family, food and the great outdoors.

Lynn Baughan

RN, MN, CDE

Lynn is a Registered Nurse with more than forty. Years of experience working as a Diabetes Educator caring for both children and adults. She has worked in a variety of practice settings including a tertiary care centre, community hospital, home care service provider organization and is currently employed as the chronic disease management lead for a regional home care coordination centre. Lynn is passionate about diabetes education and management having lived with type 1 diabetes for more than fifty-five years.

Susie Jin

RPh, CDE CRE

Susie is a primary care pharmacist, Certified Diabetes Educator, Certified Fitter of Compression Therapy and Certified Respiratory Educator. Within Diabetes Canada, Susie is a chapter author of the Clinical Practice Guidelines (CPGs), including the NEW Remission of Type 2 Diabetes chapter and User’s Guide, a member of the Dissemination and Implementation Committee of the CPGs, an Associate Editor for The Diabetes Communicator, and Professional Conference Co-Chair. With Wounds Canada, Susie is on the Board of Directors and a co-author of Wounds Canada Best Practice Recommendations. Provincially, Susie serves on the Ontario Immunization Advisory Committee. Susie is humbled to have received prestigious national awards: The 2020 Charles H. Best Award, given to a healthcare professional who has made a significant difference across Canada towards improving the quality of life of individuals living with diabetes; and the 2021 Diabetes Canada Educator of the Year.

Trish Molberg

RPh, CDE

Trish graduated from the University of Manitoba with a Bachelor of Science in Pharmacy in 2000 and has worked in community pharmacy since that time. She is currently Pharmacy Manager with an independent pharmacy in Calgary, as well as a diabetes educator with the interprofessional clinic, LMC Endocrinology Calgary. She is an advocate for positive change within the profession and a mentor for fellow pharmacists and pharmacy students.

Zaina Albalawi

MD, MSc, FRCPC

Zaina Albalawi is an Endocrinologist and Clinical Assistant Professor at Memorial University (MUN). Her areas of clinical and research interest include limb preservation, diabetes, health care system evaluation and clinical guideline development. She co-chairs the scientific planning committee for Office of Professional & Educational Development (OPED) at MUN, and is the Research Phase I Lead for UGME with the Faculty of Medicine. Zaina has co-authored national guidelines working with Diabetes Canada & the Canadian Cardiovascular Society (CCS), and is currently working with the International Working Group on the Diabetic Foot (IWGDF) on its upcoming 2023 guidelines. She is co-chair of the annual Diabetes Update national meeting. Outside of healthcare, you can find her at a crossfit box, reading, cross stitching, playing pretend-play with her youngest child, or trying not to lose badly with the newest family board game.

Kristin Honshorst (she/her)

MSs, Senior Manager, HCP Education and Engagement Diabetes Canada

In her role at Diabetes Canada, Kristin is responsible for professional education programs, tools, and resources to advance DC’s leadership and recognition as the most trusted knowledge expert in diabetes care. She leads the dissemination of our clinical practice Guidelines. Kristin has 15 years of experience in health and knowledge mobilization fields and experience working with health care providers and researchers. She holds a Master of Science in Social Psychology from the London School of Economics and Political Science with a focus on health programming for marginalized communities. Prior to her work with Diabetes Canada, she has held positions with Heart & Stroke, the IWK Health Centre in Halifax, The Canadian Partnership Against Cancer and The Conference Board of Canada. In her free time she likes to keep her mind and body active with running, triathlon, hiking and doing puzzles. She is the proud parent to two little humans.

Eilyn Rodriguez

MSs, Senior Manager, HCP Education and Engagement Diabetes Canada

Eilyn joined Diabetes Canada in November 2019 as Manager, Corporate Partnerships to focus on partnerships with the Finance, Insurance and Retail Pharmacy sectors, and is now leading the Lifescience sector strategy as Director of Development. In addition to her previous work in Corporate Partnerships with other charities, Eilyn brings extensive experience in developing and implementing professional development programs and continuing medical education from her time at the Ontario College of Family Physicians. Eilyn is also a chemical engineer by training and holds a Master of Applied Sciences, Chemical Engineering from the University of Toronto.

Frequently Asked Questions

Recordings will be available post-event

Add Settings
Yes. This is an online virtual event. You do not have to travel to any specific location. You can participate from the comfort of your own home or anywhere that you have internet access. The event is accessible via your desktop, laptop computer, mobile and tablet device. Wherever possible, we recommend using a desktop or laptop computer for the best user experience.
This is a one-day event which will go LIVE on Friday April 28, 2023 from 9:30 a.m. to 6:15 p.m. Eastern Standard Time (EST).
The event is designed for health-care professionals (HCP) including pharmacists, dietitians, nurses, diabetes educators and HCPs involved in diabetes care.
Yes, please register via the REGISTRATION tab. At this time, you will be asked to provide your personal information and payment. Within 24 hours after registering, you should receive an email confirming your registration. Within 48 hours prior to the April 28th event date, you will receive an email with a link to the live event platform. At the Conference start time, you will need to enter your email (same as the one entered during registration) to gain access.
Using your login credentials (this is your email), you can log in as soon as the event goes live on April 28, 2023 at 9:30 a.m. EST. Once you log in you will be taken to the virtual lobby and will be able to view welcome and instructional videos on how to navigate our virtual conference.

Much like an in-person conference you will be able to watch presentations in the virtual auditorium and participate in Question and Answer (Q&A) sessions. There is also an interactive tradeshow where you can visit a variety of diabetes related exhibits and ask questions via chat box or schedule a call to speak with a representative.
During the presentation, questions can be typed into the chat box at any time.
Virtual events bring the experience of an in-person conference to your personal computer, so just like an in-person conference, you have the freedom to pick the sessions you attend. You will be able to log into the event for 3-months on-demand, until July 28, 2023 to watch presentations, visit the exhibitor tradeshow and watch or download any information.

Note: After 6:16 p.m. EST on April 28, 2023 you will not be able to chat with booth representatives or participate in the leaderboard contest.
$35 (Diabetes Canada Professional Member)
$50 (General Registration)
No, you do not need to download or install any software to participate in our conference. Nor do you need a webcam to take part. You only need to have access to the internet.
For any technical assistance, please contact diabetesfrontlineforum@vfairs.com OR visit our virtual Help Desk depicted in the internal lobby and a vFairs representative will be available to help you.

The vFairs platform includes the following accessibility features:
-Ability to increase or decrease font size
-Read-speaker
-Colour contrast mode

Privacy
Diabetes Canada has contracted vFairs to manage registrations for this virtual conference. vFairs is committed to constantly ensuring the use of the latest state-of-the-art technology and procedures at its disposal to guarantee the security of the data hosted. vFairs will comply with the Canadian Standards Association (CSA) Model Code and will not use or disclose any person information or data otherwise than in strict accordance with the code.
Contact us via email at diabetesfrontlineforum@diabetes.ca or call 1-800-BANTING (226-8464) and our call center staff will get back to you in 1-2 business days.